Evaluation of the sexual function of female partners of men with erectile dysfunction receiving different treatment modalities: An observational study

Abstract

Objective:

To evaluate sexual functions of patients with erectile dysfunction (ED) and their female partners.

Methods:

A total of 90 consecutive ED patients who received different ED therapies and their partners and 90 consecutive controls and their partners were divided into four groups. All participants were evaluated by the 15-item international index of erectile function and the Arabic version of female sexual function index (Ar-FSFI).

Results:

All ED patients who received sildenafil demonstrated significant improvements of their erectile function compared to baseline. Their partners did not demonstrate improvements in frequency of pain during vaginal penetration (3.86 ± 0.58, 3.93 ± 0.45, p = 0.477), confidence of becoming aroused (3.86 ± 0.58, 3.93 ± 0.45, p 0.477), frequency of satisfaction with arousal (3.07 ± 0.37, 3.03 ± 0.49, p 0.712), and maintenance of lubrication (4.37 ± 0.49, 4.23 ± 0.73, p 0.354). All ED patients who received quadmix demonstrated significant improvements of their erectile function compared to baseline. Their partners did not demonstrate improvements in desire level (2.6 ± 0.67, 2.63 ± 0.85, p = 0.869) and lubrication maintenance (3.53 ± 0.82, 3.47 ± 0.82, p = 0.423). Finally, All ED patients who underwent semi rigid penile implant demonstrated significant improvements of their erectile function compared to baseline. Their female partners demonstrated significant improvements in all items of FSFI-19 compared to baseline except the frequency of pain during vaginal penetration (3.86 ± 0.58, 3.93 ± 0.45, p = 0.477), confidence of becoming aroused (3.86 ± 0.58, 3.93 ± 0.45, p = 0.477), frequency of satisfaction with arousal (3.07 ± 0.37, 3.03 ± 0.49, p = 0.712), and maintenance of lubrication (4.37 ± 0.49, 4.23 ± 0.73, p = 0.354).

Conclusions:

Sexual functions of ED males significantly improved after ED therapies. Nevertheless, some sexual functions of their partners were not positively impacted.

Keywords

ED males’ and their healthy partners’ sexual functions phospodiestrase type 5 inhibitors (sildenafil)intracorporeal injection (quadmix)penile prosthesis insertion sexual nirvana

Get full access to this article

View all access options for this article.

References

Washington

Shindel

. A once-daily dose of tadalafil for erectile dysfunction: compliance and efficacy. Drug Des Dev Ther 2010; 4: 159–171.

McCabe

Sharlip

Atalla

, et al. Definitions of sexual dysfunctions in women and men: a consensus statement from the fourth international consultation on sexual medicine 2015. J Sex Med 2016; 13(2): 135–143.

Cohen

. The challenge of erectile dysfunction management in the young man. Curr Urol Rep 2015; 16(12): 84.

Rosen

Fisher

Eardley

, et al. The multinational men’s attitudes to life events and sexuality (MALES) study: I. Prevalence of erectile dysfunction and related health concerns in the general population. Curr Med Res Opin 2004; 20(5): 607–617.

Carbone

Jr Seftel

. Erectile dysfunction. Diagnosis and treatment in older men. Geriatrics 2002; 57(9): 18–24.

Heidelbaugh

. Management of erectile dysfunction. Am Fam Physician 2010; 81(3): 305–312.

Cayan

Bozlu

Canpolat

, et al. The assessment of sexual functions in women with male partners complaining of erectile dysfunction: does treatment of male sexual dysfunction improve female partner’s sexual functions?. J Sex Marital Ther 2004; 30(5): 333–341.

Dunn

Croft

Hackett

. Satisfaction in the sex life of a general population sample. J Sex Marital Ther 2000; 26(2): 141–151.

Carroll

Bagley

. Evaluation of sexual satisfaction in partners of men experiencing erectile failure. J Sex Marital Ther 1990; 16(2): 70–78.

10.

Guay

Spark

Bansal

, et al. American Association of Clinical Endocrinologists medical guidelines for clinical practice for the evaluation and treatment of male sexual dysfunction: a couple’s problem. Endocr Pract 2003; 9(1): 77–96.

11.

Montague

Jarow

Broderick

, et al. Chapter 1: The management of erectile dysfunction: an AUA update. J Urol 2005; 174(1): 230–239.

12.

Leungwattanakij

Flynn

Hellstrom

WJG

. Intracavernosal injection and intraurethral therapy for erectile dysfunction. Urol Clin North Am 2001; 28(2): 343–354.

13.

Rosen

Riley

Wagner

, et al. The international index of erectile function (IIEF): a multidimensional scale for assessment of erectile dysfunction. Urology 1997; 49(6): 822–830.

14.

Anis

Gheit

Saied

, et al. Arabic translation of female sexual function index and validation in an Egyptian population. J Sex Med 2011; 8(12): 3370–3378.

15.

Palumbo

Bettocchi

Selvaggi

, et al. Sildenafil: efficacy and safety in daily clinical experience. Eur Urol 2001; 40(2): 176–180.

16.

Steidle

Stecher

Pace

, et al. Correlation of improved erectile function and rate of successful intercourse with improved emotional well-being assessed with the self-esteem and relationship questionnaire in men treated with sildenafil for erectile dysfunction and stratified by age. Curr Med Res Opin 2006; 22(5): 939–948.

17.

Mulhall

Simmons

. Assessment of comparative treatment satisfaction with sildenafil citrate and penile injection therapy in patients responding to both. BJU Int 2007; 100(6): 1313–1316.

18.

Falcone

Rolle

Ceruti

, et al. Prospective analysis of the surgical outcomes and patients’ satisfaction rate after the AMS spectra penile prosthesis implantation. Urology 2013; 82(2): 373–376.

19.

Akdemir

Okulu

Kayıgil

. Long-term outcomes of AMS Spectra^® penile prosthesis implantation and satisfaction rates. Int J Impot Res 2017; 29(5): 184–188.

20.

Ichikawa

Takao

Manabe

, et al. The female partner’s satisfaction with sildenaﬁl citrate treatment of erectile dysfunction. Int J Urol 2004; 11(9): 755–762.

21.

Heiman

Talley

Bailen

, et al. Sexual function and satisfaction in heterosexual couples when men are administered sildenaﬁl citrate (Viagra) for erectile dysfunction: a multicentre, randomised, double-blind, placebo-controlled trial. BJOG 2007; 114(4): 437–447.

22.

Illiano

Trama

Mancini

, et al. Peyronie’s disease may negatively impact the sexual experience of a couple and female sexual function: a single center study. Transl Androl Urol 2021; 10(2): 555–561.

23.

Meston

Freihart

Handy

, et al. Scoring and interpretation of the FSFI: what can be learned from 20 years of use?. J Sex Med 2020; 17(1): 17–25.

24.

Derogatis

Rosen

Leiblum

, et al. The female sexual distress scale (FSDS): initial validation of a standardized scale for assessment of sexually related personal distress in women. J Sex Marital Ther 2002; 28(4): 317–330.

25.

Meston

Trapnell

. Development and validation of a five factor sexual satisfaction and distress scale for women: the sexual satisfaction scale for women (SSS-W). J Sex Med 2005; 2(1): 66–81.

26.

Oksüz

Malhan

. Female sexual function index: validity and reliability analysis of Turkish adaptation. Syndrome 2005; 17: 54–60.

27.

Wiegel

Meston

Rosen

. The female sexual function index (FSFI): cross validation and development of clinical cutoff scores. J Sex Marital Ther 2005; 31(1): 1–20.

28.

Rajpurkar

Dhabuwala

. Comparison of satisfaction rates and erectile function in patients treated with sildenafil, intracavernous prostaglandin E1 and penile implant surgery for erectile dysfunction in urology practice. J Urol 2003; 170(1): 159–163.